← Back to All US Stocks

Streamex Corp. (STEX) Fundamental Analysis & AI Grade 2026

STEX Nasdaq Electromedical & Electrotherapeutic Apparatus DE CIK: 0001530766
Updated This Month • Analysis: May 20, 2026 • SEC Data: 2026-03-31
Combined AI Grade
D
92% Confidence
N/A
D
92% Conf
Pending
Analysis scheduled

📊 STEX Key Takeaways

Revenue: $-12.2M
Net Margin: 382.9%
Free Cash Flow: $-10.4M
Current Ratio: 13.90x
Debt/Equity: 0.00x
EPS: $-0.27
AI Grade: D with 92% confidence
Streamex Corp. (STEX) receives a D fundamental grade with 92% confidence from our AI analysis based on SEC 10-K filings. With revenue of -$12.2M, net profit margin of 382.9%, and return on equity (ROE) of -29.4%, Streamex Corp. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete STEX stock analysis for 2026.

Is Streamex Corp. (STEX) a Good Investment?

Claude

Streamex exhibits severe operational deterioration with catastrophic revenue collapse (-4080% YoY), massive operating losses (-35.7M), and persistent negative free cash flow (-10.4M) indicating a fundamentally broken business model. While the balance sheet remains strong with minimal debt and 159M equity, the company's current cash burn rate of 10.4M annually threatens depletion of 6.9M cash reserves within months, leaving insufficient runway for operational recovery.

Streamex Corp. Key Strengths (STEX)

Claude
  • + Strong balance sheet with 159M stockholders' equity and zero long-term debt
  • + Excellent liquidity position with 13.9x current ratio and 6.9M cash reserves providing near-term solvency buffer
  • + Minimal financial leverage reduces debt-related bankruptcy risk

STEX Stock Risks: Streamex Corp. Investment Risks

Claude
  • ! Catastrophic revenue decline (-4080% YoY) with negative gross margin (-0.1%) indicating fundamental unit economics failure
  • ! Severe cash burn with -10.4M free cash flow and -10.2M operating cash flow threatening liquidity depletion within 6-12 months
  • ! Massive net losses (-46.7M) and negative operating income (-35.7M) with no clear path to profitability evident in fundamentals

Key Metrics to Watch

Claude
  • * Operating cash flow trend - must return to positive to assess business viability
  • * Revenue stabilization and gross margin recovery - negative margins indicate product-market failure
  • * Monthly cash burn rate and runway months remaining - critical timeline metric given 6.9M cash position

Streamex Corp. (STEX) Financial Metrics & Key Ratios

Revenue
$-12.2M
Net Income
$-46.7M
EPS (Diluted)
$-0.27
Free Cash Flow
$-10.4M
Total Assets
$173.3M
Cash Position
$6.9M

💡 AI Analyst Insight

The 85.0% free cash flow margin provides substantial flexibility for dividends, buybacks, and strategic investments. Strong liquidity with a 13.90x current ratio provides a solid financial cushion.

STEX Profit Margin, ROE & Profitability Analysis

Gross Margin -0.1%
Operating Margin 293.1%
Net Margin 382.9%
ROE -29.4%
ROA -26.9%
FCF Margin 85.0%

STEX vs Healthcare Sector: How Streamex Corp. Compares

How Streamex Corp. compares to Healthcare sector averages

Net Margin
STEX 382.9%
vs
Sector Avg 12.0%
STEX Sector
ROE
STEX -29.4%
vs
Sector Avg 15.0%
STEX Sector
Current Ratio
STEX 13.9x
vs
Sector Avg 2.0x
STEX Sector
Debt/Equity
STEX 0.0x
vs
Sector Avg 0.6x
STEX Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Streamex Corp. Stock Overvalued? STEX Valuation Analysis 2026

Based on fundamental analysis, Streamex Corp. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
-29.4%
Sector avg: 15%
Net Profit Margin
382.9%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.00x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Streamex Corp. Balance Sheet: STEX Debt, Cash & Liquidity

Current Ratio
13.90x
Quick Ratio
13.30x
Debt/Equity
0.00x
Debt/Assets
8.1%
Interest Coverage
-2.93x
Long-term Debt
N/A

STEX Revenue & Earnings Growth: 5-Year Financial Trend

STEX 5-year financial data: Year 2024: Revenue $40.0K, Net Income -$29.0M, EPS $-3.95. Year 2025: Revenue $40.0K, Net Income -$10.3M, EPS $-0.75.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Streamex Corp.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.75 indicates the company is currently unprofitable.

STEX Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
85.0%
Free cash flow / Revenue

STEX Quarterly Earnings & Performance

Quarterly financial performance data for Streamex Corp. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $27.0K -$1.9M $-0.12
Q2 2025 $13.0K -$3.9M $-0.30
Q1 2025 $14.0K -$2.8M $-0.14
Q3 2024 $1.0K -$1.9M $-0.12

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Streamex Corp. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$10.2M
Cash generated from operations
Capital Expenditures
$186.0K
Investment in assets
Dividends
None
No dividend program

STEX SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Streamex Corp. (CIK: 0001530766)

📋 Recent SEC Filings

Date Form Document Action
May 28, 2026 8-K form8-k.htm View →
May 28, 2026 4 xslF345X06/ownership.xml View →
May 27, 2026 8-K form8-k.htm View →
May 22, 2026 4 xslF345X06/ownership.xml View →
May 21, 2026 4 xslF345X06/ownership.xml View →

Frequently Asked Questions about STEX

What is the AI rating for STEX?

Streamex Corp. (STEX) has an AI grade of D with 92% confidence, based on fundamental analysis of SEC EDGAR filings.

What are STEX's key strengths?

Claude: Strong balance sheet with 159M stockholders' equity and zero long-term debt. Excellent liquidity position with 13.9x current ratio and 6.9M cash reserves providing near-term solvency buffer.

What are the risks of investing in STEX?

Claude: Catastrophic revenue decline (-4080% YoY) with negative gross margin (-0.1%) indicating fundamental unit economics failure. Severe cash burn with -10.4M free cash flow and -10.2M operating cash flow threatening liquidity depletion within 6-12 months.

What is STEX's revenue and growth?

Streamex Corp. reported revenue of $-12.2M.

Does STEX pay dividends?

Streamex Corp. does not currently pay dividends.

Where can I find STEX SEC filings?

Official SEC filings for Streamex Corp. (CIK: 0001530766) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is STEX's EPS?

Streamex Corp. has a diluted EPS of $-0.27.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.

What is STEX's fundamental grade?

Based on our AI fundamental analysis in May 2026, Streamex Corp. has a D grade with 92% confidence. Review the strengths and risks sections above for full context. This is not investment advice.

Is STEX stock overvalued or undervalued?

Valuation metrics for STEX: ROE of -29.4% (sector avg: 15%), net margin of 382.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

What is STEX's AI grade for 2026?

Our dual AI analysis gives Streamex Corp. a combined D grade for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.

What is STEX's free cash flow?

Streamex Corp.'s operating cash flow is $-10.2M, with capital expenditures of $186.0K. FCF margin is 85.0%.

How does STEX compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin 382.9% (avg: 12%), ROE -29.4% (avg: 15%), current ratio 13.90 (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% DECK 87% NVDA 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: May 20, 2026 | Data as of: 2026-03-31 | Powered by Claude AI